<DOC>
	<DOC>NCT01572129</DOC>
	<brief_summary>Patients who developed an acute coronary syndrome despite dual antiplatelet therapy with aspirin and clopidogrel may benefit from a further dose of clopidogrel before a percutaneous coronary intervention. The aim of this study is to evaluate safety and effectiveness of clopidogrel reloading in patients on chronic clopidogrel therapy with acute coronary syndrome undergoing percutaneous coronary intervention.</brief_summary>
	<brief_title>Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>chronic (&gt; 10 days) therapy with clopidogrel (75 mg/day) nonSTsegment elevation acute coronary syndrome (ACS) requiring early diagnostic angiography primary percutaneous coronary intervention (PCI) for acute STsegment elevation acute myocardial infarction platelet count &lt; 70 Ã— 10^9/L high bleeding risk coronary bypass grafting in the previous 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>